Genetic and multi-omic risk assessment of Alzheimer's disease implicates core associated biological domains

被引:8
作者
Cary, Gregory A. [1 ]
Wiley, Jesse C. [2 ]
Gockley, Jake [2 ]
Keegan, Stephen [1 ]
Ganesh, Sai Sruthi Amirtha [2 ]
Heath, Laura [2 ]
Butler, Robert R. [3 ]
Mangravite, Lara M. [2 ]
Logsdon, Benjamin A. [2 ]
Longo, Frank M. [3 ]
Levey, Allan [4 ]
Greenwood, Anna K. [2 ]
Carter, Gregory W. [1 ,5 ]
机构
[1] Jackson Lab, Bar Harbor, ME USA
[2] Sage Bionetworks, Seattle, WA USA
[3] Stanford Univ, Sch Med, Stanford, CA USA
[4] Emory Univ, Atlanta, GA USA
[5] 600 Main St, Bar Harbor, ME 04609 USA
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; biological domain; endophenotype; genetics; proteomics; transcriptomics; ALZHEIMERS-DISEASE; BRAIN; CELLS;
D O I
10.1002/trc2.12461
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
INTRODUCTIONAlzheimer's disease (AD) is the predominant dementia globally, with heterogeneous presentation and penetrance of clinical symptoms, variable presence of mixed pathologies, potential disease subtypes, and numerous associated endophenotypes. Beyond the difficulty of designing treatments that address the core pathological characteristics of the disease, therapeutic development is challenged by the uncertainty of which endophenotypic areas and specific targets implicated by those endophenotypes to prioritize for further translational research. However, publicly funded consortia driving large-scale open science efforts have produced multiple omic analyses that address both disease risk relevance and biological process involvement of genes across the genome.METHODSHere we report the development of an informatic pipeline that draws from genetic association studies, predicted variant impact, and linkage with dementia associated phenotypes to create a genetic risk score. This is paired with a multi-omic risk score utilizing extensive sets of both transcriptomic and proteomic studies to identify system-level changes in expression associated with AD. These two elements combined constitute our target risk score that ranks AD risk genome-wide. The ranked genes are organized into endophenotypic space through the development of 19 biological domains associated with AD in the described genetics and genomics studies and accompanying literature. The biological domains are constructed from exhaustive Gene Ontology (GO) term compilations, allowing automated assignment of genes into objectively defined disease-associated biology. This rank-and-organize approach, performed genome-wide, allows the characterization of aggregations of AD risk across biological domains.RESULTSThe top AD-risk-associated biological domains are Synapse, Immune Response, Lipid Metabolism, Mitochondrial Metabolism, Structural Stabilization, and Proteostasis, with slightly lower levels of risk enrichment present within the other 13 biological domains.DISCUSSIONThis provides an objective methodology to localize risk within specific biological endophenotypes and drill down into the most significantly associated sets of GO terms and annotated genes for potential therapeutic targets.
引用
收藏
页数:15
相关论文
共 52 条
[1]   Alzheimer's Disease: An Update and Insights Into Pathophysiology [J].
Abubakar, Murtala Bello ;
Sanusi, Kamaldeen Olalekan ;
Ugusman, Azizah ;
Mohamed, Wael ;
Kamal, Haziq ;
Ibrahim, Nurul Husna ;
Khoo, Ching Soong ;
Kumar, Jaya .
FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
[2]   Sex and APOE ε4 genotype modify the Alzheimer's disease serum metabolome [J].
Arnold, Matthias ;
Nho, Kwangsik ;
Kueider-Paisley, Alexandra ;
Massaro, Tyler ;
Huynh, Kevin ;
Brauner, Barbara ;
MahmoudianDehkordi, Siamak ;
Louie, Gregory ;
Moseley, M. Arthur ;
Thompson, J. Will ;
St John-Williams, Lisa ;
Tenenbaum, Jessica D. ;
Blach, Colette ;
Chang, Rui ;
Brinton, Roberta D. ;
Baillie, Rebecca ;
Han, Xianlin ;
Trojanowski, John Q. ;
Shaw, Leslie M. ;
Martins, Ralph ;
Weiner, Michael W. ;
Trushina, Eugenia ;
Toledo, Jon B. ;
Meikle, Peter J. ;
Bennett, David A. ;
Krumsiek, Jan ;
Doraiswamy, P. Murali ;
Saykin, Andrew J. ;
Kaddurah-Daouk, Rima ;
Kastenmueller, Gabi .
NATURE COMMUNICATIONS, 2020, 11 (01)
[3]   The role of mitochondrial dysfunction in Alzheimer's disease pathogenesis [J].
Ashleigh, Theophania ;
Swerdlow, Russell H. ;
Beal, M. Flint .
ALZHEIMERS & DEMENTIA, 2023, 19 (01) :333-342
[4]   Open drug discovery in Alzheimer's disease [J].
Axtman, Alison. D. E. ;
Brennan, Paul. E. ;
Frappier-Brinton, Tristan ;
Betarbet, Ranjita W. ;
Carter, Gregory. W. ;
Fu, Haian ;
Gileadi, Opher K. ;
Greenwood, Anna. K. ;
Leal, Karina M. ;
Longo, Frank. M. M. ;
Mangravite, Lara. M. M. ;
Edwards, Aled. M. I. ;
Levey, Allan., I .
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2023, 9 (02)
[5]   Multi-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer's disease [J].
Baloni, Priyanka ;
Arnold, Matthias ;
Buitrago, Luna ;
Nho, Kwangsik ;
Moreno, Herman ;
Huynh, Kevin ;
Brauner, Barbara ;
Louie, Gregory ;
Kueider-Paisley, Alexandra ;
Suhre, Karsten ;
Saykin, Andrew J. ;
Ekroos, Kim ;
Meikle, Peter J. ;
Hood, Leroy ;
Price, Nathan D. ;
Doraiswamy, P. Murali ;
Funk, Cory C. ;
Hernandez, A. Ivan ;
Kastenmueller, Gabi ;
Baillie, Rebecca ;
Han, Xianlin ;
Kaddurah-Daouk, Rima .
COMMUNICATIONS BIOLOGY, 2022, 5 (01)
[6]   New insights into the genetic etiology of Alzheimer's disease and related dementias [J].
Bellenguez, Celine ;
Kucukali, Fahri ;
Jansen, Iris E. ;
Kleineidam, Luca ;
Moreno-Grau, Sonia ;
Amin, Najaf ;
Naj, Adam C. ;
Campos-Martin, Rafael ;
Grenier-Boley, Benjamin ;
Andrade, Victor ;
Holmans, Peter A. ;
Boland, Anne ;
Damotte, Vincent ;
van der Lee, Sven J. ;
Costa, Marcos R. ;
Kuulasmaa, Teemu ;
Yang, Qiong ;
De Rojas, Itziar ;
Bis, Joshua C. ;
Yaqub, Amber ;
Prokic, Ivana ;
Chapuis, Julien ;
Ahmad, Shahzad ;
Giedraitis, Vilmantas ;
Aarsland, Dag ;
Garcia-Gonzalez, Pablo ;
Abdelnour, Carla ;
Alarcon-Martin, Emilio ;
Alcolea, Daniel ;
Alegret, Montserrat ;
Alvarez, Ignacio ;
Alvarez, Victoria ;
Armstrong, Nicola J. ;
Tsolaki, Anthoula ;
Antunez, Carmen ;
Appollonio, Ildebrando ;
Arcaro, Marina ;
Archetti, Silvana ;
Arias Pastor, Alfonso ;
Arosio, Beatrice ;
Athanasiu, Lavinia ;
Bailly, Henri ;
Banaj, Nerisa ;
Baquero, Miquel ;
Barral, Sandra ;
Beiser, Alexa ;
Pastor, Ana Belen ;
Below, Jennifer E. ;
Benchek, Penelope ;
Benussi, Luisa .
NATURE GENETICS, 2022, 54 (04) :412-436
[7]   Chaperone-mediated autophagy: a gatekeeper of neuronal proteostasis [J].
Bourdenx, Mathieu ;
Gavathiotis, Evripidis ;
Cuervo, Ana Maria .
AUTOPHAGY, 2021, 17 (08) :2040-2042
[8]   Incidence of cognitively defined late-onset Alzheimer's dementia subgroups from a prospective cohort study [J].
Crane, Paul K. ;
Trittschuh, Emily ;
Mukherjee, Shubhabrata ;
Saykin, Andrew J. ;
Sanders, R. Elizabeth ;
Larson, Eric B. ;
McCurry, Susan M. ;
McCormick, Wayne ;
Bowen, James D. ;
Grabowski, Thomas ;
Moore, Mackenzie ;
Bauman, Julianna ;
Gross, Alden L. ;
Keene, C. Dirk ;
Bird, Thomas D. ;
Gibbons, Laura E. ;
Mez, Jesse .
ALZHEIMERS & DEMENTIA, 2017, 13 (12) :1307-1316
[9]   Alzheimer's disease drug development pipeline: 2022 [J].
Cummings, Jeffrey ;
Lee, Garam ;
Nahed, Pouyan ;
Kambar, Mina Esmail Zadeh Nojoo ;
Zhong, Kate ;
Fonseca, Jorge ;
Taghva, Kazem .
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2022, 8 (01)
[10]   Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies [J].
Dejanovic, Borislav ;
Huntley, Melanie A. ;
De Maziere, Ann ;
Meilandt, William J. ;
Wu, Tiffany ;
Srinivasan, Karpagam ;
Jiang, Zhiyu ;
Gandham, Vineela ;
Friedman, Brad A. ;
Hai Ngu ;
Foreman, Oded ;
Carano, Richard A. D. ;
Chih, Ben ;
Klumperman, Judith ;
Bakalarski, Corey ;
Hanson, Jesse E. ;
Sheng, Morgan .
NEURON, 2018, 100 (06) :1322-+